(JHG) Janus Henderson - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: JE00BYPZJM29
Stock: Asset Management, Funds, Investments, Portfolios
Total Rating 56
Risk 61
Buy Signal 0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 25.5% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.92 |
| Alpha | 5.70 |
| Character TTM | |
|---|---|
| Beta | 1.260 |
| Beta Downside | 1.945 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.29% |
| CAGR/Max DD | 0.85 |
EPS (Earnings per Share)
Revenue
Description: JHG Janus Henderson March 05, 2026
Janus Henderson Group plc (JHG) is an asset management holding company. It serves institutional, retail, and high-net-worth clients.
The firm manages separate equity and fixed-income portfolios, as well as mutual funds. Asset managers typically charge fees based on assets under management (AUM).
JHG specializes in growth capital, middle-market, and buyout investments. The company invests in public equity, fixed income, real estate, and private equity markets. Private equity involves investing in companies not listed on a public exchange.
Investment focuses include commercial services, logistics, consumer goods, healthcare, and diversified financial services. JHG invests in companies in China and India, with individual investments ranging from $10 million to $30 million. For more in-depth analysis, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 797.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -5.12 > 1.0 |
| NWC/Revenue: 39.73% < 20% (prev 77.01%; Δ -37.27% < -1%) |
| CFO/TA 0.04 > 3% & CFO 322.7m > Net Income 797.6m |
| Net Debt (-858.4m) to EBITDA (867.3m): -0.99 < 3 |
| Current Ratio: 53.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (150.4m) vs 12m ago -2.84% < -2% |
| Gross Margin: 70.78% > 18% (prev 0.69%; Δ 7009 % > 0.5%) |
| Asset Turnover: 40.62% > 50% (prev 35.52%; Δ 5.10% > 0%) |
| Interest Coverage Ratio: 34.34 > 6 (EBITDA TTM 867.3m / Interest Expense TTM 24.2m) |
Altman Z'' 4.73
| A: 0.15 (Total Current Assets 1.25b - Total Current Liabilities 23.3m) / Total Assets 8.29b |
| B: 0.14 (Retained Earnings 1.18b / Total Assets 8.29b) |
| C: 0.11 (EBIT TTM 831.0m / Avg Total Assets 7.63b) |
| D: 2.43 (Book Value of Equity 5.28b / Total Liabilities 2.17b) |
| Altman-Z'' Score: 4.73 = AA |
Beneish M
| DSRI: none (Receivables none/432.7m, Revenue 3.10b/2.47b) |
| GMI: 0.97 (GM 70.78% / 68.69%) |
| AQI: 1.37 (AQ_t 0.84 / AQ_t-1 0.62) |
| SGI: 1.25 (Revenue 3.10b / 2.47b) |
| TATA: 0.06 (NI 797.6m - CFO 322.7m) / TA 8.29b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of JHG shares?
As of March 05, 2026, the stock is trading at USD 51.40 with a total of 1,917,378 shares traded.
Over the past week, the price has changed by +2.49%, over one month by +6.75%, over three months by +15.87% and over the past year by +34.31%.
Over the past week, the price has changed by +2.49%, over one month by +6.75%, over three months by +15.87% and over the past year by +34.31%.
Is JHG a buy, sell or hold?
Janus Henderson has received a consensus analysts rating of 3.45.
Therefor, it is recommend to hold JHG.
- StrongBuy: 2
- Buy: 1
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the JHG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.1 | -2.5% |
| Analysts Target Price | 50.1 | -2.5% |
JHG Fundamental Data Overview March 05, 2026
P/E Trailing = 9.8738
P/E Forward = 12.0919
P/S = 2.5688
P/B = 1.475
P/EG = 1.0894
Revenue TTM = 3.10b USD
EBIT TTM = 831.0m USD
EBITDA TTM = 867.3m USD
Long Term Debt = 395.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -858.4m USD (from netDebt column, last quarter)
Enterprise Value = 7.10b USD (7.96b + Debt 395.5m - CCE 1.25b)
Interest Coverage Ratio = 34.34 (Ebit TTM 831.0m / Interest Expense TTM 24.2m)
EV/FCF = 18.18x (Enterprise Value 7.10b / FCF TTM 390.5m)
FCF Yield = 5.50% (FCF TTM 390.5m / Enterprise Value 7.10b)
FCF Margin = 12.61% (FCF TTM 390.5m / Revenue TTM 3.10b)
Net Margin = 25.75% (Net Income TTM 797.6m / Revenue TTM 3.10b)
Gross Margin = 70.78% ((Revenue TTM 3.10b - Cost of Revenue TTM 905.1m) / Revenue TTM)
Gross Margin QoQ = 73.19% (prev 70.67%)
Tobins Q-Ratio = 0.86 (Enterprise Value 7.10b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 22.10% (120.9m / 547.1m)
NOPAT = 647.4m (EBIT 831.0m * (1 - 22.10%))
Current Ratio = 53.82 (Total Current Assets 1.25b / Total Current Liabilities 23.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -0.99 (Net Debt -858.4m / EBITDA 867.3m)
Debt / FCF = -2.20 (Net Debt -858.4m / FCF TTM 390.5m)
Total Stockholder Equity = 4.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.46% (Net Income 797.6m / Total Assets 8.29b)
RoE = 16.35% (Net Income TTM 797.6m / Total Stockholder Equity 4.88b)
RoCE = 15.76% (EBIT 831.0m / Capital Employed (Equity 4.88b + L.T.Debt 395.5m))
RoIC = 12.59% (NOPAT 647.4m / Invested Capital 5.14b)
WACC = 10.12% (E(7.96b)/V(8.35b) * Re(10.56%) + D(395.5m)/V(8.35b) * Rd(1.54%) * (1-Tc(0.22)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.11%
[DCF] Terminal Value 71.42% ; FCFF base≈508.1m ; Y1≈527.6m ; Y5≈602.5m
[DCF] Fair Price = 55.49 (EV 7.43b - Net Debt -858.4m = Equity 8.29b / Shares 149.4m; r=10.12% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 69.63 | Revenue CAGR: 17.70% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.32 | Chg7d=+0.250 | Chg30d=+0.252 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.48 | Chg7d=-0.033 | Chg30d=+0.107 | Revisions Net=+2 | Growth EPS=-6.3% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=4.84 | Chg7d=+0.000 | Chg30d=+0.086 | Revisions Net=+3 | Growth EPS=+8.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.4% (Discount Rate 10.6% - Earnings Yield 10.1%)
[Growth] Growth Spread = +15.5% (Analyst 15.9% - Implied 0.4%)
P/E Forward = 12.0919
P/S = 2.5688
P/B = 1.475
P/EG = 1.0894
Revenue TTM = 3.10b USD
EBIT TTM = 831.0m USD
EBITDA TTM = 867.3m USD
Long Term Debt = 395.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 395.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -858.4m USD (from netDebt column, last quarter)
Enterprise Value = 7.10b USD (7.96b + Debt 395.5m - CCE 1.25b)
Interest Coverage Ratio = 34.34 (Ebit TTM 831.0m / Interest Expense TTM 24.2m)
EV/FCF = 18.18x (Enterprise Value 7.10b / FCF TTM 390.5m)
FCF Yield = 5.50% (FCF TTM 390.5m / Enterprise Value 7.10b)
FCF Margin = 12.61% (FCF TTM 390.5m / Revenue TTM 3.10b)
Net Margin = 25.75% (Net Income TTM 797.6m / Revenue TTM 3.10b)
Gross Margin = 70.78% ((Revenue TTM 3.10b - Cost of Revenue TTM 905.1m) / Revenue TTM)
Gross Margin QoQ = 73.19% (prev 70.67%)
Tobins Q-Ratio = 0.86 (Enterprise Value 7.10b / Total Assets 8.29b)
Interest Expense / Debt = 1.54% (Interest Expense 6.10m / Debt 395.5m)
Taxrate = 22.10% (120.9m / 547.1m)
NOPAT = 647.4m (EBIT 831.0m * (1 - 22.10%))
Current Ratio = 53.82 (Total Current Assets 1.25b / Total Current Liabilities 23.3m)
Debt / Equity = 0.07 (Debt 395.5m / totalStockholderEquity, last quarter 5.28b)
Debt / EBITDA = -0.99 (Net Debt -858.4m / EBITDA 867.3m)
Debt / FCF = -2.20 (Net Debt -858.4m / FCF TTM 390.5m)
Total Stockholder Equity = 4.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.46% (Net Income 797.6m / Total Assets 8.29b)
RoE = 16.35% (Net Income TTM 797.6m / Total Stockholder Equity 4.88b)
RoCE = 15.76% (EBIT 831.0m / Capital Employed (Equity 4.88b + L.T.Debt 395.5m))
RoIC = 12.59% (NOPAT 647.4m / Invested Capital 5.14b)
WACC = 10.12% (E(7.96b)/V(8.35b) * Re(10.56%) + D(395.5m)/V(8.35b) * Rd(1.54%) * (1-Tc(0.22)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.11%
[DCF] Terminal Value 71.42% ; FCFF base≈508.1m ; Y1≈527.6m ; Y5≈602.5m
[DCF] Fair Price = 55.49 (EV 7.43b - Net Debt -858.4m = Equity 8.29b / Shares 149.4m; r=10.12% [WACC]; 5y FCF grow 4.04% → 2.90% )
EPS Correlation: 78.20 | EPS CAGR: 30.07% | SUE: 4.0 | # QB: 7
Revenue Correlation: 69.63 | Revenue CAGR: 17.70% | SUE: 4.0 | # QB: 1
EPS next Quarter (2026-06-30): EPS=1.32 | Chg7d=+0.250 | Chg30d=+0.252 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=4.48 | Chg7d=-0.033 | Chg30d=+0.107 | Revisions Net=+2 | Growth EPS=-6.3% | Growth Revenue=-3.0%
EPS next Year (2027-12-31): EPS=4.84 | Chg7d=+0.000 | Chg30d=+0.086 | Revisions Net=+3 | Growth EPS=+8.2% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.4% (Discount Rate 10.6% - Earnings Yield 10.1%)
[Growth] Growth Spread = +15.5% (Analyst 15.9% - Implied 0.4%)